Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 116

1.

Hyperlactataemia in HIV-infected subjects initiating antiretroviral therapy in a large randomized study (a substudy of the INITIO trial).

Feeney ER, Chazallon C, O'Brien N, Meiffrédy V, Goodall RL, Aboulker JP, Cooper DA, Yeni P, Mallon PW; INITIO Trial International Co-ordinating Committee.

HIV Med. 2011 Nov;12(10):602-9. doi: 10.1111/j.1468-1293.2011.00934.x. Epub 2011 May 22.

PMID:
21599820
[PubMed - indexed for MEDLINE]
2.

Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy.

Casula M, Weverling GJ, Wit FW, Timmermans EC, Stek M Jr, Lange JM, Reiss P.

J Infect Dis. 2005 Nov 15;192(10):1794-800. Epub 2005 Oct 12.

PMID:
16235179
[PubMed - indexed for MEDLINE]
Free Article
3.

Matched case-control study to evaluate risk factors for hyperlactataemia in HIV patients on antiretroviral therapy.

Datta D, Moyle G, Mandalia S, Gazzard B.

HIV Med. 2003 Oct;4(4):311-4.

PMID:
14525541
[PubMed - indexed for MEDLINE]
4.

Lactic acidosis and symptomatic hyperlactataemia in a randomized trial of first-line therapy in HIV-infected adults in South Africa.

Dlamini J, Ledwaba L, Mokwena N, Mokhathi T, Orsega S, Tsoku M, Kowo H, Proschan M, Khabo P, Maja P, Hadigan C.

Antivir Ther. 2011;16(4):605-9. doi: 10.3851/IMP1790.

PMID:
21685549
[PubMed - indexed for MEDLINE]
5.

A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients.

Ruxrungtham K, Kroon ED, Ungsedhapand C, Teeratakulpisarn S, Ubolyam S, Buranapraditkun S, van Leeuwen R, Weverling GJ, Kunanusont C, Lange JM, Cooper DA, Phanuphak P.

AIDS. 2000 Jul 7;14(10):1375-82.

PMID:
10930152
[PubMed - indexed for MEDLINE]
6.

Mitochondrial DNA depletion in adipose tissue of HIV-infected patients with peripheral lipoatrophy.

Buffet M, Schwarzinger M, Amellal B, Gourlain K, Bui P, Prévot M, Deleuze J, Morini JP, Gorin I, Calvez V, Dupin N.

J Clin Virol. 2005 May;33(1):60-4.

PMID:
15797366
[PubMed - indexed for MEDLINE]
7.

A randomized study comparing triple versus double antiretroviral therapy or no treatment in HIV-1-infected patients in very early stage disease: the Spanish Earth-1 study.

García F, Romeu J, Grau I, Sambeat MA, Dalmau D, Knobel H, Gomez-Sirvent JL, Arrizabalaga J, Cruceta A, Clotet BG, Podzamczer D, Pumarola T, Gallart T, O'Brien WA, Miró JM, Gatell JM.

AIDS. 1999 Dec 3;13(17):2377-88.

PMID:
10597779
[PubMed - indexed for MEDLINE]
8.

Virological and immunological responses to once-daily dosing of didanosine in combination with stavudine. AI454-143 Team.

Mobley JE, Pollard RB, Schrader S, Adler MH, Kelleher T, McLaren C.

AIDS. 1999 Jul 30;13(11):F87-93.

PMID:
10449279
[PubMed - indexed for MEDLINE]
9.

Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study.

McComsey GA, Lo Re V 3rd, O'Riordan M, Walker UA, Lebrecht D, Baron E, Mounzer K, Frank I.

Clin Infect Dis. 2008 Apr 15;46(8):1290-6. doi: 10.1086/529384.

PMID:
18444869
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Depletion of mitochondrial DNA copies/cell in peripheral blood mononuclear cells in HIV-1-infected treatment-naïve patients.

Maagaard A, Holberg-Petersen M, Kvittingen EA, Sandvik L, Bruun JN.

HIV Med. 2006 Jan;7(1):53-8.

PMID:
16313293
[PubMed - indexed for MEDLINE]
11.

Assessment of adipokine expression and mitochondrial toxicity in HIV patients with lipoatrophy on stavudine- and zidovudine-containing regimens.

Jones SP, Qazi N, Morelese J, Lebrecht D, Sutinen J, Yki-Jărvinen H, Back DJ, Pirmohamed M, Gazzard BG, Walker UA, Moyle GJ.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):565-72.

PMID:
16284533
[PubMed - indexed for MEDLINE]
12.

Common inherited mitochondrial DNA mutations and nucleoside reverse transcriptase inhibitor-induced severe hyperlactataemia in HIV-infected adults: an exploratory study.

Arenas-Pinto A, Weller I, Ekong R, Grant A, Karstaedt A, Reiss P, Telisinghe L, Weber R, Bolhaar M, Bradman N, Ingram C.

Antivir Ther. 2012;17(2):275-82. doi: 10.3851/IMP1947. Epub 2011 Nov 7. Erratum in: Antivir Ther. 2012;17(6):1103-4.

PMID:
22293466
[PubMed - indexed for MEDLINE]
13.

Depletion of mitochondrial DNA in liver under antiretroviral therapy with didanosine, stavudine, or zalcitabine.

Walker UA, Bäuerle J, Laguno M, Murillas J, Mauss S, Schmutz G, Setzer B, Miquel R, Gatell JM, Mallolas J.

Hepatology. 2004 Feb;39(2):311-7.

PMID:
14767983
[PubMed - indexed for MEDLINE]
14.

Combination therapy with stavudine (d4T) plus didanosine (ddI) in children with human immunodeficiency virus infection. The Pediatric AIDS Clinical Trials Group 327 Team.

Kline MW, Van Dyke RB, Lindsey JC, Gwynne M, Culnane M, Diaz C, Yogev R, McKinney RE Jr, Abrams EJ, Mofenson LM.

Pediatrics. 1999 May;103(5):e62.

PMID:
10224206
[PubMed - indexed for MEDLINE]
15.

Impact of nucleoside reverse transcriptase inhibitors on mitochondria in human immunodeficiency virus type 1-infected children receiving highly active antiretroviral therapy.

Saitoh A, Fenton T, Alvero C, Fletcher CV, Spector SA.

Antimicrob Agents Chemother. 2007 Dec;51(12):4236-42. Epub 2007 Sep 24.

PMID:
17893156
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

The safety profile and antiviral activity of the combination of stavudine, didanosine, and nelfinavir in patients with HIV infection.

Elion R, Kaul S, Knupp C, Adler M, Cross AP, Dunkle LM, Kelleher T.

Clin Ther. 1999 Nov;21(11):1853-63.

PMID:
10890257
[PubMed - indexed for MEDLINE]
17.

Didanosine dosed once daily is equivalent to twice daily dosing for patients on double or triple combination antiretroviral therapy. The AI454-147 Team.

Kazatchkine MD, Van PN, Costagliola D, Mohammed AS, Ledeine JM, Troccaz M, Belec L.

J Acquir Immune Defic Syndr. 2000 Aug 15;24(5):418-24.

PMID:
11035612
[PubMed - indexed for MEDLINE]
18.

Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy.

Miura T, Goto M, Hosoya N, Odawara T, Kitamura Y, Nakamura T, Iwamoto A.

J Med Virol. 2003 Aug;70(4):497-505.

PMID:
12794710
[PubMed - indexed for MEDLINE]
19.

Comparison of once and twice daily dosing of didanosine in combination with stavudine for the treatment of HIV-1 infection. AI 454-146 Team.

Monno L, Cargnel A, Soranzo ML, Chirianni A, Ferraro T, Di Stefano M, Angarano G.

Antivir Ther. 1999;4(4):195-202.

PMID:
10723498
[PubMed - indexed for MEDLINE]
20.

A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II).

Eron JJ Jr, Murphy RL, Peterson D, Pottage J, Parenti DM, Jemsek J, Swindells S, Sepulveda G, Bellos N, Rashbaum BC, Esinhart J, Schoellkopf N, Grosso R, Stevens M.

AIDS. 2000 Jul 28;14(11):1601-10.

PMID:
10983647
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk